Monday's News for Neurologists: Here's 246 New Studies from 10/1 to Monday 10/28:

AUDIT ON INTRAVENOUS IMMUNOGLOBULIN (IVIG) USE IN ABERDEEN ROYAL INFIRMARY NEUROLOGY DEPARTMENT ACCORDING TO 2005 ASSOCIATION OF BRITISH NEUROLOGISTS (ABN) GUIDELINES.

AUTOANTIBODIES IN GLIOMA PATIENTS: IMMUNE BIOMARKERS FOR IDENTIFICATION OF LOW GRADE TUMOURS.

TOWARDS AN ENDOPHENOTYPE IN MULTIPLE SCLEROSIS.

EPISTATIC EFFECTS ON THE PHENOTYPE OF MULTIPLE SCLEROSIS.

SODIUM ACCUMULATION IS ASSOCIATED WITH DISABILITY AND PROGRESSION IN MULTIPLE SCLEROSIS: A 23NA MRI STUDY.

THERAPY RELATED ACUTE LEUKAEMIA WITH MITOXANTRONE: 4 YEARS ON, WHAT IS THE RISK AND CAN IT BE LIMITED?

LATE-ONSET MULTIPLE SCLEROSIS IN SOUTH-EAST WALES.

AUTOLOGOUS MESENCHYMAL STEM CELLS FOR THE TREATMENT OF SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS: AN OPEN-LABEL PHASE 2A PROOF-OF-CONCEPT STUDY.

CSF ANALYSIS AND THE DIAGNOSIS OF NEUROMYELITIS OPTICA.

THE ROLE OF BRAIN MRI IN THE DIAGNOSIS OF NEUROMYELITIS OPTICA.

USE OF SERVICES FOR MULTIPLE SCLEROSIS PATIENTS ACCORDING TO EDSS.

A SURVEY OF ADVICE ON DRIVING IN NEUROLOGICAL CONDITIONS AMONGST NEUROLOGISTS AND NEUROSURGEONS.

What Not to Prescribe: APA List Aims to Make Patients Safer

Neurologists mad about British guidance on MS drugs Fampyra, Sativex

Click here to read